These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15658303)

  • 1. [Tartrate resistant acid phosphatase].
    Yoh K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():215-9. PubMed ID: 15658303
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tartrate resistant acid phosphatase].
    Yoh K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():349-53. PubMed ID: 15035150
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tartrate resistant acid phosphatase--TRACP-5b as a modern bone resorption marker].
    Nowak Z; Konieczna M; Saracyn M; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):351-4. PubMed ID: 18634372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.
    Halleen JM
    Anticancer Res; 2003; 23(2A):1027-9. PubMed ID: 12820342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
    Halleen JM; Alatalo SL; Janckila AJ; Woitge HW; Seibel MJ; Väänänen HK
    Clin Chem; 2001 Mar; 47(3):597-600. PubMed ID: 11238321
    [No Abstract]   [Full Text] [Related]  

  • 6. Tartrate-resistant acid phosphatase as a serum marker of bone resorption.
    Halleen JM; Ranta R
    Am Clin Lab; 2001 Jul; 20(6):29-30. PubMed ID: 11480390
    [No Abstract]   [Full Text] [Related]  

  • 7. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.
    Halleen JM; Tiitinen SL; Ylipahkala H; Fagerlund KM; Väänänen HK
    Clin Lab; 2006; 52(9-10):499-509. PubMed ID: 17078477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of analyses of acid phosphatase 5b bone isoenzyme in patients with osteopenia and osteoporosis (pilot study)].
    Stejskal D; Zurek M; Svecová R; Zapletalová J; Bartek J; Oral I; Horalík D; Lacnák B; Jedelský L; Lenobelová H
    Vnitr Lek; 2001 Jan; 47(1):60-2. PubMed ID: 15635870
    [No Abstract]   [Full Text] [Related]  

  • 9. [TARTRAT-RESISTANT ACID PHOSPHATASE AS BONE'S RESORBTION MARKER IN PATIENTS WITH BONE METASTASES].
    Dedkov AG; Boychuk SI; Stakhovsky EA; Kukushkina MN; Kovalchuk PA
    Lik Sprava; 2015; (5-6):104-9. PubMed ID: 27089726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development for the determination of band 5b tartrate-resistant acid phosphatase activity in serum].
    Uchida K; Nakanishi M; Yoh K
    Rinsho Byori; 2001 Jan; 49(1):51-5. PubMed ID: 11215484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption.
    Halleen JM; Alatalo SL; Suominen H; Cheng S; Janckila AJ; Väänänen HK
    J Bone Miner Res; 2000 Jul; 15(7):1337-45. PubMed ID: 10893682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
    Jung K; Lein M; Ringsdorf M; Roigas J; Schnorr D; Loening SA; Staack A
    J Urol; 2006 Oct; 176(4 Pt 1):1326-31. PubMed ID: 16952623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer.
    Capeller B; Caffier H; Sütterlin MW; Dietl J
    Anticancer Res; 2003; 23(2A):1011-5. PubMed ID: 12820340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and clinical significance of tartrate-resistant acid phosphatases: new perspectives on an old enzyme.
    Janckila AJ; Yam LT
    Calcif Tissue Int; 2009 Dec; 85(6):465-83. PubMed ID: 19915788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased tartrate-resistant acid phosphatase serum levels in ankylosing spondylitis and relationship with the inflammatory process.
    Toussirot E; Dumoulin G; Saas P; Nguyen NU; Le Huédé G; Wendling D
    Ann Rheum Dis; 2008 Mar; 67(3):430-1. PubMed ID: 18292108
    [No Abstract]   [Full Text] [Related]  

  • 16. Tartrate-resistant acid phosphatase as a marker of bone metastases in patients with breast cancer and prostate cancer.
    Lyubimova NV; Pashkov MV; Tyulyandin SA; Gol'dberg VE; Kushlinskii NE
    Bull Exp Biol Med; 2004 Jul; 138(1):77-9. PubMed ID: 15514730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases.
    Tauchert S; di Liberto A; Cordes T; Thill M; Salehin D; Friedrich M
    Clin Exp Obstet Gynecol; 2009; 36(4):219-25. PubMed ID: 20101852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tartrate-resistant acid phosphatase isoform 5b (TRACP 5b) as a serum maker for cancer with bone metastasis.
    Chao TY; Wu YY; Janckila AJ
    Clin Chim Acta; 2010 Nov; 411(21-22):1553-64. PubMed ID: 20599857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):108-15. PubMed ID: 18084692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of bone turnover: biochemical and clinical perspectives.
    Pagani F; Francucci CM; Moro L
    J Endocrinol Invest; 2005; 28(10 Suppl):8-13. PubMed ID: 16550716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.